McKesson Beefs Up Oncology Business With $575 Million OTN Buy
This article was originally published in The Pink Sheet Daily
Executive Summary
Oncology Therapeutics Network has $3 billion in annualized sales, which is likely to grow with new deal to provide oral cancer agents to UnitedHealthcare.
You may also be interested in...
McKesson Extends Reach Of Specialty Drug Business With With US Oncology Acquisition
The $2.16 billion transaction bolsters McKesson's high-growth specialty business.
McKesson Extends Reach Of Specialty Drug Business With With US Oncology Acquisition
The $2.16 billion transaction bolsters McKesson's high-growth specialty business.
Cardinal Expands Retail Pharmacy Offerings, Eschews Specialty Drug Businesses
Cardinal increases independent pharmacy segment with acquisition of F. Dohmen and ParMed distributors.